Form 4: Replimune Group CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Emily Luisa Hill, CFO of Replimune Group, sold 2,535 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On May 20, 2025, Emily Luisa Hill, the Chief Financial Officer of Replimune Group, Inc., sold 2,535 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the partial vesting of her Restricted Stock Units (RSUs).
- The shares were sold at a weighted average price of $8.05, with individual transactions ranging from $8.05 to $8.79 per share.
- Following the transaction, Hill directly owns 143,522 shares of Replimune Group, Inc.
- The sale was conducted according to a pre-existing 'sell to cover' provision in her RSU award agreements, not as a discretionary sale.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (sale of shares for tax obligations). It's neutral in sentiment as it doesn't indicate any significant positive or negative developments for the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives. This transaction is a routine part of executive compensation and does not necessarily indicate a change in the executive's confidence in the company.
Comparison to Industry Standards
- Executive stock sales for tax obligations are a standard practice across publicly traded companies.
- Similar transactions are regularly reported by executives at companies like Amgen, Gilead Sciences, and Bristol-Myers Squibb.
- The size of the sale (2,535 shares) is relatively small compared to the total shares owned (143,522), suggesting it's a routine tax-related transaction rather than a significant divestment.
Stakeholder Impact
- The sale of shares by the CFO could have a minor, temporary impact on the stock price, but it's unlikely to be significant given the relatively small number of shares involved.
- The transaction is part of the CFO's compensation package and doesn't directly affect employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of the stock sale transaction. |
| 05/22/2025 | Date of signature on the Form 4 filing. |
Keywords
Replimune Group, Emily Luisa Hill, CFO, Form 4, Share Sale, Restricted Stock Units, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.